System updates will be applied on February 19, 2026 at 6:00 PM. These updates will include changes to the user interface. Work is expected to take approximately 30 minutes to complete, during which the site will be unavailable.

	
Amend CSHB 2292 as follows:                                                  
	Section 2.12. On page 70, line 13, insert new subsections 
(a-1) and (a-2) to read as follows:
	(a-1) The commission shall delay requiring a prior 
authorization for drugs listed in subsection (b) until the 
commission has completed a study evaluating the impact of a 
requirement of prior authorization on the recipients of certain 
drug classes.
	(a-2) Drugs subject to the study in subsection (b) include 
drugs used in the treatment of:
		(1) cancer and cancer-supportive care,                                 
		(2) End-stage Renal Disease,                                           
		(3) chronic non-malignant pain,                                        
		(4) hemophilia, and                                                    
		(5) multiple sclerosis.